Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 4, 2009, Pages

  Goto, Junko ^a   Otsuka, Fumio ^a   Yamashita, Misuzu ^a   Suzuki, Jiro ^a   Otani, Hiroyuki ^a   Takahashi, Hiroko ^a   Miyoshi, Tomoko ^a   Mimura, Yukari ^a   Ogura, Toshio ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Aldosterone; c Jun NH2 terminal kinase; Eplerenone; Mineralocorticoid receptor; Pheochromocytoma; Stress activated protein kinase

Indexed keywords

ALDOSTERONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BONE MORPHOGENETIC PROTEIN 4; CATECHOLAMINE; CYCLOHEXIMIDE; DEXAMETHASONE; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOGENIC PROTEIN 1; RHO FACTOR; STRESS ACTIVATED PROTEIN KINASE; TYROSINE 3 MONOOXYGENASE; BONE MORPHOGENETIC PROTEIN; CELL RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ADRENAL MEDULLA; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENAL MEDULLA; ALDOSTERONE; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; CATECHOLAMINES; DRUG SYNERGISM; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASE 8; MODELS, BIOLOGICAL; PC12 CELLS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 65649098455     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90840.2008     Document Type: Article

References (70)

1. Agarwal AK, Mune T, Monder C, White PC. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J Biol Chem 269: 25959-25962, 1994. (Pubitemid 24978861)
2. Aherne AM, Vaughan CJ, Carey RM, O'Connell DP. Localization of dopamine D1A receptor protein and messenger ribonucleic acid in rat adrenal cortex. Endocrinology 138: 1282-1288, 1997.
3. Alzamora R, Marusic ET, Gonzalez M, Michea L. Nongenomic effect of aldosterone on Na+,K+-adenosine triphosphatase in arterial vessels. Endocrinology 144: 1266-1272, 2003. (Pubitemid 36428468)
4. Amenta F, Ricci A. Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland. Clin Exp Hypertens 17: 669-688, 1995.
5. Bevilacqua M, Vago T, Scorza D, Norbiato G. Characterization of dopamine receptors by 3H-ADTN binding in calf adrenal zona glomerulosa. Biochem Biophys Res Commun 108: 1661-1669, 1982.
6. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 78: 225-232, 1994. (Pubitemid 24026776)
7. Brown JW, Fishman LM, Carballeira A. Studies of the neuronal transdifferentiation process in cultured human pheochromocytoma cells: effects of steroids with differing functional groups on catecholamine content and cell morphology. Steroids 63: 587-594, 1998. (Pubitemid 28525427)
8. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45: 773-779, 2005. (Pubitemid 40418380)
9. Carey RM, Thorner MO, Ortt EM. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest 63: 727-735, 1979.
10. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem 271: 5289-5292, 1996.
11. Chun TY, Pratt JH. Non-genomic effects of aldosterone: new actions and questions. Trends Endocrinol Metab 15: 353-354, 2004.
12. Cole TJ. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136: 4693-4696, 1995.
13. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
14. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988. (Pubitemid 18254266)
15. Fitzpatrick SC, McKenna TJ. Dopamine inhibition of potassium-stimulated aldosterone biosynthesis in bovine adrenal zona glomerulosa cells. J Steroid Biochem 32: 715-718, 1989.
16. Fuenzalida KM, Aguilera MC, Piderit DG, Ramos PC, Contador D, Quinones V, Rigotti A, Bronfman FC, Bronfman M. Peroxisome proliferator-activated receptor gamma is a novel target of the nerve growth factor signaling pathway in PC12 cells. J Biol Chem 280: 9604-9609, 2005. (Pubitemid 40409656)
17. Funder JW. The nongenomic actions of aldosterone. Endocr Rev 26: 313-321, 2005.
18. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988. (Pubitemid 18263202)
19. Gallagher ED, Gutowski S, Sternweis PC, Cobb MH. RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279: 1872-1877, 2004. (Pubitemid 38084456)
20. Ganguly A. Dopaminergic regulation of aldosterone secretion: how credible? Clin Sci (Lond) 66: 631-637, 1984. (Pubitemid 14145915)
21. Ganguly A, Davis JS. Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. Pharmacol Rev 46: 417-447, 1994.
22. Gekle M, Freudinger R, Mildenberger S, Schenk K, Marschitz I, Schramek H. Rapid activation of Na+/H+-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2. Pflugers Arch 441: 781-786, 2001. (Pubitemid 32186544)
23. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 386: 193-205, 2005. (Pubitemid 40485425)
24. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73: 2424-2428, 1976.
25. Grossmann C, Benesic A, Krug AW, Freudinger R, Mildenberger S, Gassner B, Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol 19: 1697-1710, 2005. (Pubitemid 41007884)
26. Hendron E, Stockand JD. Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone. Mol Biol Cell 13: 3042-3054, 2002.
27. Horky K, Kopecka J, Widimsky J Jr, Gregorva I, Tesar P. Urinary excretion of catecholamines in patients with primary aldosteronism before and after unilateral adrenalectomy. Cor Vasa 25: 401-412, 1983.
28. Inagaki K, Otsuka F, Suzuki J, Kano Y, Takeda M, Miyoshi T, Otani H, Mimura Y, Ogura T, Makino H. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells. Endocrinology 147: 2681-2689, 2006. (Pubitemid 43764604)
29. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 10: 205-219, 1998.
30. Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A, Yoshizumi M. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 46: 1046-1052, 2005.
31. Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17: 15R-22R, 2007. (Pubitemid 46432006)
32. Kano Y, Otsuka F, Takeda M, Suzuki J, Inagaki K, Miyoshi T, Miyamoto M, Otani H, Ogura T, Makino H. Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells. Endocrinology 146: 5332-5340, 2005. (Pubitemid 41653046)
33. Kuchel O, Buu NT, Unger T, Genest J. Free and conjugated catecholamines in human hypertension. Clin Sci Mol Med Suppl 4: 77s-80s, 1978.
34. Kvanta A, Fredholm BB. Synergistic effects between protein kinase C and cAMP on activator protein-1 activity and differentiation of PC-12 pheochromocytoma cells. J Mol Neurosci 4: 205-214, 1993.
35. Kvetnansky R, Micutkova L, Rychkova N, Kubovcakova L, Mravec B, Filipenko M, Sabban EL, Krizanova O. Quantitative evaluation of catecholamine enzymes gene expression in adrenal medulla and sympathetic Ganglia of stressed rats. Ann NY Acad Sci 1018: 356-369, 2004. (Pubitemid 38951429)
36. Le Moellic C, Ouvrard-Pascaud A, Capurro C, Cluzeaud F, Fay M, Jaisser F, Farman N, Blot-Chabaud M. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J Am Soc Nephrol 15: 1145-1160, 2004. (Pubitemid 38525996)
37. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118, 2005. (Pubitemid 40261799)
38. Liu J, Minemoto Y, Lin A. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24: 10844-10856, 2004. (Pubitemid 39603140)
39. Liu SL, Schmuck S, Chorazcyzewski JZ, Gros R, Feldman RD. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 108: 2400-2406, 2003. (Pubitemid 37413549)
40. McKenna TJ, Island DP, Nicholson WE, Liddle GW. Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells. J Clin Invest 64: 287-291, 1979.
41. Mehler MF, Mabie PC, Zhang D, Kessler JA. Bone morphogenetic proteins in the nervous system. Trends Neurosci 20: 309-317, 1997. (Pubitemid 27348741)
42. Michea L, Delpiano AM, Hitschfeld C, Lobos L, Lavandero S, Marusic ET. Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 146: 973-980, 2005. (Pubitemid 40289282)
43. Missale C, Liberini P, Memo M, Carruba MO, Spano P. Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa. Endocrinology 119: 2227-2232, 1986. (Pubitemid 17171407)
44. Missale C, Lombardi C, De Cotiis R, Memo M, Carruba MO, Spano PF. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview. J Cardiovasc Pharmacol 14, Suppl 8: S29-S39, 1989. (Pubitemid 20056575)
45. Miyoshi T, Otsuka F, Otani H, Inagaki K, Goto J, Yamashita M, Ogura T, Iwasaki Y, Makino H. Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells. J Endocrinol 197: 159-169, 2008.
46. Nanmoku T, Takekoshi K, Fukuda T, Ishii K, Isobe K, Kawakami Y. Stimulation of catecholamine biosynthesis via the PKC pathway by prolactin-releasing peptide in PC12 rat pheochromocytoma cells. J Endocrinol 186: 233-239, 2005. (Pubitemid 41015680)
47. Náray-Fejes-Tóth, A, Fejes-Tóth G .Extranuclear localization of endogenous 11beta-hydroxysteroid dehydrogenase-2 in aldosterone target cells. Endocrinology 139: 2955-2959, 1998. (Pubitemid 28512408)
48. Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J, Mukai T, Ogura T, Makino H. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. Am J Physiol Renal Physiol 292: F1513-F1525, 2007. (Pubitemid 46701879)
49. Otsuka F, Shimasaki S. A novel function of bone morphogenetic protein- 15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143: 4938-4941, 2002. (Pubitemid 35397634)
50. Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 171: 1-10, 2001. (Pubitemid 32727350)
51. Reissmann E, Ernsberger U, Francis-West PH, Rueger D, Brickell PM, Rohrer H. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 122: 2079-2088, 1996. (Pubitemid 26235808)
52. Roland BL, Funder JW. Localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology 137: 1123-1128, 1996.
53. Rossol-Haseroth K, Zhou Q, Braun S, Boldyreff B, Falkenstein E, Wehling M, Losel RM. Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone. Biochem Biophys Res Commun 318: 281-288, 2004. (Pubitemid 38526277)
54. Schinner S, Bornstein SR. Cortical-chromaffin cell interactions in the adrenal gland. Endocr Pathol 16: 91-98, 2005. (Pubitemid 41400349)
55. Schmidt BM, Christ M, Falkenstein E, Wehling M. Nongenomic steroid actions: completing the puzzle. Aldosterone as an example. Exp Clin Endocrinol Diabetes 106: 441-445, 1998. (Pubitemid 29015300)
56. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25: 72-101, 2004. (Pubitemid 38292039)
57. Shirai H, Autieri M, Eguchi S. Small GTP-binding proteins and mitogen- activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens 16: 111-115, 2007. (Pubitemid 46254930)
58. Smith RE, Li KX, Andrews RK, Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 138: 540-547, 1997. (Pubitemid 27110899)
59. Stockand JD, Meszaros JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 284: H176-H184, 2003.
60. Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY, Kimura S, Kiyomoto H, Ohmori K, Li DT, Abe Y, Nishiyama A. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 17: 2193-2201, 2006. (Pubitemid 44141909)
61. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T, Makino H. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 145: 639-649, 2004. (Pubitemid 38183806)
62. Suzuki J, Otsuka F, Takeda M, Inagaki K, Miyoshi T, Mimura Y, Ogura T, Doihara H, Makino H. Functional roles of the bone morphogenetic protein system in thyrotropin signaling in porcine thyroid cells. Biochem Biophys Res Commun 327: 1124-1130, 2005. (Pubitemid 40137984)
63. Takeda M, Otsuka F, Otani H, Inagaki K, Miyoshi T, Suzuki J, Mimura Y, Ogura T, Makino H. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells. J Endocrinol 194: 87-99, 2007. (Pubitemid 47162890)
64. Takeda M, Otsuka F, Suzuki J, Kishida M, Ogura T, Tamiya T, Makino H. Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochem Biophys Res Commun 306: 812-818, 2003. (Pubitemid 36776203)
65. Uhrenholt TR, Schjerning J, Hansen PB, Norregaard R, Jensen BL, Sorensen GL, Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 93: 1258-1266, 2003. (Pubitemid 37547959)
66. Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell 116: 491-497, 2004. (Pubitemid 38264427)
67. Varley JE, Maxwell GD. BMP-2 and BMP-4, but not BMP-6, increase the number of adrenergic cells which develop in quail trunk neural crest cultures. Exp Neurol 140: 84-94, 1996.
68. Varley JE, Wehby RG, Rueger DC, Maxwell GD. Number of adrenergic and islet-1 immunoreactive cells is increased in avian trunk neural crest cultures in the presence of human recombinant osteogenic protein-1. Dev Dyn 203: 434-447, 1995.
69. Wurtman RJ, Pohorecky LA, Baliga BS. Adrenocortical control of the biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmacol Rev 24: 411-426, 1972.
70. Zigmond RE, Schwarzschild MA, Rittenhouse AR. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12: 415-461, 1989.